Sepantronium Bromide (YM155) Enhances Response of Human B-Cell Non-Hodgkin Lymphoma to Rituximab-Reference-Cited by-同舟云学术

Sepantronium Bromide (YM155) Enhances Response of Human B-Cell Non-Hodgkin Lymphoma to Rituximab

Published:2012-07-11 Issue:1 Volume:343 Page:178-183
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Kita Aya,Mitsuoka Keisuke,Kaneko Naoki,Nakata Mari,Yamanaka Kentaro,Jitsuoka Makoto,Miyoshi Sosuke,Noda Akihiro,Mori Masamichi,Nakahara Takahito,Sasamata Masao

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference30 articles.

1. The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo

2. Prognostic significance of survivin expression in diffuse large B-cell lymphomas;Adida;Blood,2000

3. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma;Alas;Clin Cancer Res,2002

4. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

5. Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism;Lymphatics;2024-03-28

2. Survivin Small Molecules Inhibitors: Recent Advances and Challenges;Molecules;2023-02-01

3. Altered pathways and targeted therapy in double hit lymphoma;Journal of Hematology & Oncology;2022-03-18

4. Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma;Cancers;2021-04-30

5. Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma;BMC Veterinary Research;2020-03-24